The blood thinner drug Xarelto (generic: rivaroxaban) has recently been linked to severe, potentially fatal internal bleeding events and other serious side effects.
Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Xarelto, you should contact our law firm immediately. You may be entitled to compensation by filing a class action suit against the manufacturer and our lawyers can help.
Update: J&J, Bayer Ordered to Pay $28 Million in Xarelto GI Bleeding Lawsuit
December 6, 2017 – Bayer AG and J&J have been found liable and ordered to pay nearly $28 million to a woman who claimed Xarelto caused her to develop severe internal bleeding injuries. Plaintiffs secured a much-needed win the Xarelto litigation, as Bayer and J&J had emerged victorious in the previous 3 bellwether trials.
What is Xarelto?
Xarelto is a widely-prescribed anticoagulant medication that is used for 3 primary purposes:
- To reduce the risk of blood clot and stroke in patients diagnosed with atrial fibrillation (afib)
- For the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)
- To reduce the risk of blood clot in patients undergoing knee or hip replacement surgery.
Xarelto is classified as a direct factor Xa inhibitor medication. Also called blood thinners, anticoagulants disrupt the blood’s normal clotting process. Clotting is a natural process that helps stop bleeding from an open wound, but some people develop blood clots when they are not injured. Afib is a heart condition characterized by an irregular heartbeat which can cause blood to accumulate in the heart, increasing the risk of blood clots. If these clots migrate to the brain, they can cause a stroke. Blood clots that form in the legs (deep vein thrombosis) and pulmonary embolism (blood clots in the lungs) can cause severe health complications including death if they are left untreated.
Xarelto Side Effects
When people experience side effects they suspect were caused by a medication, they may report the events to the FDA. These side effects are logged in the agency’s Adverse Events Reporting System (AERS). A company called Adverse Events, Inc. has developed software that analyzes the information to provide data about injuries suffered by patients across the U.S. To date, there have been over 2,100 reports involving Xarelto, with at least 1,821 listing the medicine as the primary suspect for an injury.
The most common serious side effects linked to Xarelto include:
- Pulmonary Embolism (386 reports)
- Deep Vein Thrombosis (279 reports)
- Gastrointestinal hemorrhage (107 reports)
- Hemorrhage (107 reports)
Other adverse events associated with Xarelto use included thrombosis, hemoglobin decrease, cerebrovascular accidents, hematoma, edema peripheral and dyspnea. Hospitalization was reported in 891 cases; sadly, 183 patients died after taking Xarelto.
ISMP QuarterWatch Links Xarelto to 15,000 Adverse Event Reports in 2016
July 18, 2017 – Xarelto was linked to at least 15,043 adverse event reports last year, according to the latest ISMP QuarterWatch Report. A total of 21,996 injuries were associated with the entire class of blood-thinners, nearly 70% of which were tied to Xarelto.
First Xarelto Trial Kicks Off in New Orleans
April 24, 2017 – The first of 4 bellwether trials alleging bleeding side effects from Xarelto is now underway in Louisiana federal court. The complaint was filed by Joseph Boudreaux, who claims he experienced severe internal bleeding less than a month after taking Xarelto for the first time. His injuries required a week-long stay in an ICU, numerous blood transfusions and heart procedures, according to the lawsuit.
Xarelto Lawsuit Filed in Vermont
September 27, 2016 – The daughter of a man who allegedly died from an uncontrollable brain bleed after taking Xarelto has filed a products liability lawsuit in Vermont. Plaintiff’s father had only been taking the drug a short time when he fell and sustained a brain bleed, which caused a intracerebral hemorrhage. He eventually died from the bleeding, according to the lawsuit.
Nearly 7,000 Lawsuits Consolidated in Xarelto Litigation
August 15, 2016 – The number of lawsuits in the Xarelto multidistrict litigation (MDL) has grown to at least 6,600, with nearly 1,000 complaints filed in the last month alone. With so many cases in the MDL and more on the way, plaintiffs eagerly await results of the bellwether trials, which are scheduled to begin early next year. These cases will set the tone for future litigation, and show both sides what the experts have to say about Xarelto side effects.
Has Xarelto Been Recalled?
Despite being linked to thousands of injuries, no recall has been issued for Xarelto, and the drug continues to be prescribed to patients across the country. A growing number of lawsuits have called for the drug to be recalled until an antidote or reversal agent can be developed to stop bleeding caused by Xarelto. However, it appears likely that the drug will stay on the market for the foreseeable future.
Is There a Class Action?
The Xarelto litigation is not currently being handled as a class action. Instead, our lawyers are filing individual lawsuits for people who were injured by the drug. These complaints are being combined into a multidistrict litigation (MDL) in the U.S. District Court, Eastern District of Louisiana. Unlike a class action, MDL lawsuits remain separate, and no client is forced to settle their case as part of a class action group. Additionally, each client in an MDL gets to make their own decision whether or not to go to trial.
Have There Been Any Settlements?
To date, there have been no large group settlements in the Xarelto litigation. This is because complex pharmaceutical litigation often takes years to resolve, and large settlements do not typically occur until several cases are tried before a jury. However, this does not mean you should wait to hire an attorney if you’ve been injured by Xarelto. Just the opposite, in fact – if you wait you could lose your legal rights even if a settlement is reached. This is because each state has a time limit (statute of limitations, or SOL) in which to file a claim.
Xarelto Bellwether Trials Begin in Louisiana
April 4, 2017 – Judge Eldon Fallon is set to begin hearing the first Xarelto bellwether trials later this month, and the cases are being watched very closely as outcomes could help to determine future rulings. The first trial is scheduled to begin on April 24, with another beginning each month until July. Since the cases involve complex pharmaceutical litigation, each trial could last up to 8 weeks before a jury returns a verdict.
Do I Have a Xarelto Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Xarelto Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
Free Confidential Case Evaluation: Again, if you or a loved one has been injured by Xarelto side effects, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.